Orchestra BioMed director granted RSUs and options
Orchestra BioMed Holdings, Inc. director Pamela Ann Connealy received equity compensation in the form of restricted stock units and stock options.
Rhea-AI Filing Summary
Orchestra BioMed Holdings, Inc. director Pamela Ann Connealy received equity compensation in the form of restricted stock units and stock options. She was granted 17,327 RSUs, each representing one future share of Common Stock, which vest on the one-year anniversary of the June 23, 2026 grant date, subject to continued service.
She also received stock options for 21,277 shares of Common Stock at an exercise price of $4.0400 per share, expiring on June 23, 2036, which vest on the same one-year schedule. Following the RSU award, her direct Common Stock holdings total 66,038 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 38,604 shares
Grant/Award
2 txns
Insider
Connealy Pamela Ann
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 21,277 | $0.00 | $0.00 |
| Grant/Award | Common Stock, par value $0.0001 per share ("Common Stock") | 17,327 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 21,277 contracts (Direct);
Common Stock, par value $0.0001 per share ("Common Stock") — 66,038 shares (Direct)
Footnotes (2)
- F1. Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on June 23, 2026 (the "Grant Date"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date.
- F2. The stock options will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date.
Key Figures
RSUs granted: 17,327 RSUs
Options granted: 21,277 options
Option exercise price: $4.0400 per share
+2 more
5 metrics
RSUs granted
17,327 RSUs
Awarded June 23, 2026, vest after one year
Options granted
21,277 options
Grant for Common Stock, vest after one year
Option exercise price
$4.0400 per share
Stock Option (Right to Buy) for Common Stock
Option expiration
June 23, 2036
Expiration date of stock options
Shares held after grant
66,038 shares
Total Common Stock directly owned after RSU award
Key Terms
restricted stock units, Common Stock, Stock Option (Right to Buy), exercise price, +1 more
5 terms
restricted stock units financial
"Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on June 23, 2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Common Stock financial
"Each RSU represents a contingent right to receive one share of Common Stock."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price": "4.0400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
continuous service other
"subject to the Reporting Person's continuous service through such date."
FAQ
What equity awards did Pamela Ann Connealy receive from OBIO?
Pamela Ann Connealy received 17,327 restricted stock units and stock options for 21,277 shares. The RSUs convert into Common Stock at vesting, and the options allow future purchases at a fixed price, forming part of her director compensation package.
When do Pamela Ann Connealy’s OBIO RSUs and options vest?
Both the 17,327 RSUs and the 21,277 stock options vest on the one-year anniversary of the June 23, 2026 grant date. Vesting requires her to maintain continuous service with Orchestra BioMed Holdings through that one-year period to receive the awards.
What is the exercise price of Pamela Ann Connealy’s OBIO stock options?
The granted stock options have an exercise price of $4.0400 per share. This means she can buy up to 21,277 shares of Orchestra BioMed Holdings Common Stock at $4.0400 each once the options vest and before they expire in 2036.
When do Pamela Ann Connealy’s OBIO stock options expire?
The stock options granted to Pamela Ann Connealy expire on June 23, 2036. She must wait until the options vest after one year, then may choose to exercise them any time before this expiration date, subject to applicable company and plan rules.
Are Pamela Ann Connealy’s OBIO equity awards open-market purchases?
No, these are compensation-related awards, not open-market purchases. The Form 4 shows an acquisition coded as a grant of RSUs and stock options, reflecting equity granted by Orchestra BioMed Holdings as part of her director compensation, with no cash purchase reported.
AI-generated analysis. How Rhea-AI works. Not financial advice.
